SCHEMBL20037599

SCHEMBL20037599

CNc1ccc(N2CCCNCC2=O)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.51
SLC6A4 P31645 2/20 0.51
SLC6A3 Q01959 2/20 0.51
CDK4 P11802 7/20 0.41
CDK6 Q00534 3/20 0.41
MAP4K1 Q92918 1/20 0.39
CHRNB2 P17787 4/20 0.37
CHRNA4 P43681 4/20 0.37
CCND1 P24385 6/20 0.36
CCND3 P30281 5/20 0.36
CCNT1 O60563 2/20 0.36
CDK9 P50750 2/20 0.36
CDK7 P50613 1/20 0.36
CCNH P51946 1/20 0.36
MNAT1 P51948 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
AKR1C3 P42330 1/20 0.35
HTR6 P50406 1/20 0.34
HCAR3 P49019 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20038005 0.82 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3CDK4CDK6
SCHEMBL18291536 0.81 SLC6A2 (0.56) SLC6A2SLC6A4SLC6A3CDK4CDK6
SCHEMBL20037516 0.80 SLC6A2 (0.55) SLC6A2SLC6A4SLC6A3CDK4CDK6
SCHEMBL20249262 0.79 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CHRNB2CHRNA4
SCHEMBL21414444 0.79 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CDK4CDK6
SCHEMBL20203434 0.79 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3CDK4CDK6
SCHEMBL21414350 0.75 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3CDK4CDK6
SCHEMBL255543 0.73 SLC6A2 (0.43) SLC6A2SLC6A4SLC6A3CDK4CDK6
SCHEMBL21017102 0.73 TYK2 (0.48) MAP4K1F10
SCHEMBL158236 0.72 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed